Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambroxol inhalation for sticky sputum in adult respiratory disease
ChiCTR2100043736Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ambroxol in Airways Infection, acute bronchitis, chronic bronchitis (CB) and 3 more, sponsored by The First Affiliated Hospital of Guangzhou Medical University. Primary endpoints: Change in sputum character score and Difficulty of expectoration score. Planned start Jul 2020; status: not yet recruiting.
02
Drugs
ambroxol
03
Conditions
Airways Infectionacute bronchitischronic bronchitis (CB)pneumoniachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR2100043736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043736.